Abstract
A single intraperitoneal injection of 0.5 mg methotrexate (MTX) has been found to increase the immune reactivity of spleen cells from (C57B1/6 X DBA/2)F1 mice. Five days after injection, spleen cells from MTX-treated mice exhibited greater PHA responsiveness and GvH reactivity, and mice given SRBC at this time developed greater than normal direct PFC responses. This pattern of effects of MTX was particularly evident in mice that had been given high doses of BCG intravenously 14 days before testing, a treatment that generally depressed the measured activities. MTX enhancement of GvH was also observed in mice that had been depleted of short-lived T lymphocytes by adult thymectomy. We suggest that MTX-sensitive cells possible exert, particularly in BCG-treated mice, a suppressive action on the responding cells.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Askenase P. W., Hayden B. J., Gershon R. K. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med. 1975 Mar 1;141(3):697–702. doi: 10.1084/jem.141.3.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cunningham A. J., Szenberg A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 1968 Apr;14(4):599–600. [PMC free article] [PubMed] [Google Scholar]
- Ford W. L., Simonsen M. The factor of immunization in the rat. The effect of allogeneic immunization on graft-versus-host activity. J Exp Med. 1971 Apr 1;133(4):938–949. doi: 10.1084/jem.133.4.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gershon R. K., Hencin R. S. The DNA synthetic response of adoptively transferred thymocytes in the spleens of lethally irradiated mice. I. Effects of varying antigen and thymocyte doses. J Immunol. 1971 Dec;107(6):1723–1728. [PubMed] [Google Scholar]
- Gershon R. K., Liebhaber S. A. The response of T cells to histocompatibility-2 antigens. Dose-response kinetics. J Exp Med. 1972 Jul 1;136(1):112–127. doi: 10.1084/jem.136.1.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guttmann R. D. Membrane properties and functional activity of lymphocytes from cyclophosphamide-pretreated rats. J Immunol. 1974 Apr;112(4):1594–1601. [PubMed] [Google Scholar]
- Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
- Katz S. I., Parker D., Turk J. L. B-cell suppression of delayed hypersensitivity reactions. Nature. 1974 Oct 11;251(5475):550–551. doi: 10.1038/251550a0. [DOI] [PubMed] [Google Scholar]
- Kerckhaert J. A., Van den Berg G. J., Willers J. M. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Ann Immunol (Paris) 1974 Mar-Apr;125(3):415–426. [PubMed] [Google Scholar]
- Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neta R., Salvin S. B. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol. 1974 Dec;113(6):1716–1725. [PubMed] [Google Scholar]
- Orbach-Arbouys S., Poupon M. F. Active suppression of in vitro reactivity of spleen cells after BCG treatment. Immunology. 1978 Mar;34(3):431–437. [PMC free article] [PubMed] [Google Scholar]
- Orbach-Arbouys S. Rupture de la tolérance immunitaire par certains cytostatiques utilisés en chimiothérapie anticancéreuse. Rev Fr Etud Clin Biol. 1968 Dec;13(10):1014–1016. [PubMed] [Google Scholar]
- Willers J. M., Sluis E. The influence of cyclophosphamide on antibody formation in the mouse. Ann Immunol (Paris) 1975 Apr;126(3):267–279. [PubMed] [Google Scholar]